Biosensors,
Journal Year:
2023,
Volume and Issue:
13(9), P. 857 - 857
Published: Aug. 29, 2023
Point-of-care
tests
play
an
important
role
in
serological
diagnostics
of
infectious
diseases
and
post-vaccination
immunity
monitoring,
including
COVID-19.
Currently,
lateral
flow
dominate
this
area
show
good
analytical
performance.
However,
studies
to
improve
the
effectiveness
such
remain
important.
In
comparison
with
tests,
vertical
immunoassays
allow
for
a
reduction
assay
duration
influence
hook
effect.
Additionally,
use
carbon
black
nanoparticles
(CNPs)
as
color
label
can
provide
lower
detection
limit
(LOD)
compared
conventional
colloidal
gold.
Therefore,
we
have
developed
immunoassay
IgG
against
SARS-CoV-2
spike
protein
human
serum
samples
by
applying
conjugate
CNPs
anti-human
mouse
monoclonal
antibodies
(CNP@MAb).
The
device
consists
plastic
cassette
hole
on
its
top
containing
nitrocellulose
membrane
coated
absorbent
pad.
sample,
washing
buffer,
CNP@MAb
vertically
through
pads,
reducing
time
simplifying
procedure.
positive
samples,
interaction
anti-spike
leads
appearance
spots,
which
be
visually
detected.
method
allows
rapid
visual
(5–7
min)
vs.
protein,
LOD
7.81
BAU/mL.
It
has
been
shown
that
untrained
operator
perform
evaluate
results.
Thus,
presented
used
further
development
test
systems
COVID-19
or
monitoring.
Analytical Chemistry,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Sept. 23, 2024
Lateral
flow
immunoassay
(LFIA)
is
valued
for
its
simplicity
and
rapidity
on-site
screening,
however,
it
experienced
false
negatives
in
real
sample
analysis
due
to
low
sensitivity.
Although
many
signal
amplification
techniques
can
improve
the
sensitivity,
they
usually
require
additional
complicated
steps.
To
address
these
issues,
taking
BioChem,
Journal Year:
2024,
Volume and Issue:
4(3), P. 268 - 299
Published: Sept. 23, 2024
The
COVID-19
pandemic,
instigated
by
the
emergence
of
novel
coronavirus,
SARS-CoV-2,
created
an
incomparable
global
health
crisis.
Due
to
its
highly
virulent
nature,
identifying
potential
therapeutic
agents
against
this
lethal
virus
is
crucial.
PLpro
a
key
protein
involved
in
viral
polyprotein
processing
and
immune
system
evasion,
making
it
prime
target
for
development
antiviral
drugs
combat
COVID-19.
To
expedite
search
candidates,
review
delved
into
computational
studies.
Recent
investigations
have
harnessed
methods
identify
promising
inhibitors
targeting
PLpro,
aiming
suppress
activity.
Molecular
docking
techniques
were
employed
researchers
explore
binding
sites
within
catalytic
region
PLpro.
elucidates
functional
structural
properties
SARS-CoV-2
underscoring
significance
pathogenicity
replication.
Through
comprehensive
all-atom
molecular
dynamics
(MD)
simulations,
stability
drug–PLpro
complexes
was
assessed,
providing
dynamic
insights
their
interactions.
By
evaluating
energy
estimates
from
MD
stable
with
identified.
This
offers
overview
drug/lead
candidates
discovered
thus
far
using
diverse
silico
methodologies,
encompassing
drug
repurposing,
structure-based,
ligand-based
virtual
screenings.
Additionally,
identified
are
listed
based
on
chemical
structures
meticulously
examined
according
various
parameters,
such
as
estimated
free
(ΔG),
types
intermolecular
interactions,
PLpro–ligand
complexes,
determined
outcomes
simulations.
Underscoring
pivotal
role
battle
COVID-19,
establishes
robust
foundation
integrating
modeling,
insights.
continual
imperative
improvement
existing
exploring
compounds
remains
paramount
efforts
evolution
management
hinge
symbiotic
relationship
between
experimental
validation,
interdisciplinary
synergy
crucial
endeavor.
Molecules,
Journal Year:
2024,
Volume and Issue:
29(20), P. 4900 - 4900
Published: Oct. 16, 2024
Until
now,
Z-form
RNAs
were
believed
to
only
adopt
a
left-handed
double-helix
structure.
In
this
study,
we
describe
the
first
observation
of
right-handed
RNA
in
NMR
solution
formed
by
L-nucleic
acid
and
present
resolution
structure
complex
between
curaxin
ligand.
These
results
provide
platform
for
design
topology
specific
Z-form-targeting
compounds
are
valuable
development
new
potent
anticancer
drugs.
BMC Infectious Diseases,
Journal Year:
2024,
Volume and Issue:
24(1)
Published: Dec. 18, 2024
The
COVID-19
has
put
emphasis
on
pivotal
needs
for
diagnosis
and
surveillance
worldwide,
with
the
subsequent
shortage
of
diagnostic
reagents
kits.
Therefore,
it
become
strategic
countries
to
access
diagnostics,
expand
testing
capacity,
develop
their
own
capabilities
alternative
rapid
accurate
nucleic
acid
diagnostics
that
are
at
lower
costs.
Here,
we
propose
a
visual
SARS-CoV-2
detection
using
one-step
fast
multiplex
reverse
transcription-PCR
(RT-PCR)
amplification
coupled
lateral
flow
immunoassay
PCRD
device
(Abingdon
Health,
UK).
We
developed
various
simplex
fast-PCRs
screening
sets
primer
pairs
newly
designed
or
selected
from
literature
validated
WHO
targeting
S,
N,
E,
RdRp
ORF1ab
genes.
retained
primers
showing
specific
stable
assess
suitability
PCRD.
Thus,
RT-PCR
amplifications
were
performed
primers.
They
doubly
labeled
Fam
Biotin
Dig
allow
amplicons
PCR
Detection
(PCRD)
device,
looking
lack
interaction
(or
dimers)
test-lines
in
negative
no
RNA
controls.
set
up
all
assays
RNAs
isolated
patients'
nasopharyngeal
swabs.
used
two
assays,
different
viral
genomic
regions
(N
E)
PCRD,
assay
(where
both
differently
engaged)
amplicons'
device.
evaluated
this
novel
50
positive
samples
compared
its
performance
results
quantitative
(RT-qPCR)
diagnosing
patients,
here
considered
as
standard
tests.
new
achieved
sensitivity
88%
(44/50)
specificity
98%
(49/50).
All
patients
who
presented
Ct
values
than
33
our
assay.
Except
one
patient,
those
above
returned
results.
Our
have
brought
proof
principle
usefulness
RT-
specific,
sensitive,
without
requiring
costly
laboratory
equipment,
thus,
reduced
costs
format
prone
be
deployed
when
resources
limited.
This
offers
viable
points
need.
Biosensors,
Journal Year:
2023,
Volume and Issue:
13(9), P. 857 - 857
Published: Aug. 29, 2023
Point-of-care
tests
play
an
important
role
in
serological
diagnostics
of
infectious
diseases
and
post-vaccination
immunity
monitoring,
including
COVID-19.
Currently,
lateral
flow
dominate
this
area
show
good
analytical
performance.
However,
studies
to
improve
the
effectiveness
such
remain
important.
In
comparison
with
tests,
vertical
immunoassays
allow
for
a
reduction
assay
duration
influence
hook
effect.
Additionally,
use
carbon
black
nanoparticles
(CNPs)
as
color
label
can
provide
lower
detection
limit
(LOD)
compared
conventional
colloidal
gold.
Therefore,
we
have
developed
immunoassay
IgG
against
SARS-CoV-2
spike
protein
human
serum
samples
by
applying
conjugate
CNPs
anti-human
mouse
monoclonal
antibodies
(CNP@MAb).
The
device
consists
plastic
cassette
hole
on
its
top
containing
nitrocellulose
membrane
coated
absorbent
pad.
sample,
washing
buffer,
CNP@MAb
vertically
through
pads,
reducing
time
simplifying
procedure.
positive
samples,
interaction
anti-spike
leads
appearance
spots,
which
be
visually
detected.
method
allows
rapid
visual
(5–7
min)
vs.
protein,
LOD
7.81
BAU/mL.
It
has
been
shown
that
untrained
operator
perform
evaluate
results.
Thus,
presented
used
further
development
test
systems
COVID-19
or
monitoring.